Tom J Parry is a notable inventor based in Walkersville, MD (US). He has made significant contributions to the field of biotechnology, particularly in the modulation of ACE-2 activity. With a total of 2 patents to his name, Parry's work has implications for diagnosing and treating various diseases.

Latest Patents

Parry's latest patents focus on methods and compositions for modulating ACE-2 activity. One patent discloses binding polypeptides that specifically bind to ACE-2 protein or ACE-2-like polypeptides. These binding polypeptides can be utilized for detecting, isolating, or purifying ACE-2 in biological samples. Additionally, the invention includes nucleic acid molecules encoding these polypeptides, as well as methods for producing them. Another patent relates to the use of angiotensin II in combination with angiotensin 1-9 to enhance vasoconstriction and treat disorders associated with low blood pressure.

Career Highlights

Tom J Parry is currently associated with Human Genome Sciences, Inc., where he continues to innovate in the field of genetic research and biotechnology. His work has contributed to advancements in understanding ACE-2's role in various health conditions.

Collaborations

Throughout his career, Parry has collaborated with notable colleagues such as Les Sekut and Craig A Rosen. These collaborations have further enriched his research and development efforts.

Conclusion

Tom J Parry's innovative work in biotechnology, particularly regarding ACE-2 modulation, showcases his significant contributions to the field. His patents reflect a commitment to advancing medical science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.